An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Investigational Treatment Gaining Traction Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to contact these accounts directly for source information, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers market the drug there before redirecting customers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Express Worries
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to users administering substances of uncertain source.
Several professionals stated the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, marketing, and customer laws, risking fines, legal action or imprisonment.
Platform Reaction and Content Elimination
According to the social media company, the platform has removed violative content and prohibited associated hashtags and query recommendations. The company stated it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.
Digital Trading Operations
Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at residence.
After minutes of entering one community, a vendor posted contact information, where most purchases occur. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about body mass, health issues or past usage.
Item Details and Costs
Within these communities, messages show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how long a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.
Service Oversight and Security Actions
A representative for Telegram said it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they can’t verify. Although the research behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has previously seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to possibly serious health risks”.
